Brand: Category Use Cases: , , , Form:

This peptide is offered in two variations: 2mg and 5mg.

Our Ipamorelin for sale is a pentapeptide, which displays high GH releasing potency and efficacy in vitro and in vivo. Ipamorelin is the first GHRP-receptor agonist with a selectivity for GH release similar to that displayed by GHRH. The specificity of Ipamorelin makes this compound a very interesting candidate for future clinical development.

Ipamorelin is a research peptide that stimulates the release of growth hormone (GH). It is composed of five amino acids and is thus known as a pentapeptide. Ipamorelin is often lumped together with CJC 1295, though they are two different compounds.

Ipamorelin was originally developed by Novo Nordisk Inc. It was investigated in phase 2 trials as a treatment for postoperative ileus, a condition in which the bowel stops functioning after surgical procedures. However, due to lack of efficacy, it was discontinued.

Pharmacological profiling using growth hormone-releasing peptide (GHRP) and growth-hormone-releasing hormone (GHRH) antagonists has clearly demonstrated that Ipamorelin stimulates GH release via a GH-like receptor. Its selectivity for GH is similar to that displayed by GHRH.

Buy Now

onpeptides.com participates in the Amazon Associates Associates Program, an affiliate advertising program designed to provide a means for sites to earn commissions by linking to Amazon. This means that whenever you buy a product on Amazon from a link on here, we get a small percentage of its price.

onpeptides.com does not offer medical diagnosis or treatment advice we make no claims that the products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

This information has not been evaluated by the Food and Drug Administration (FDA).